12 CORE Functions
Triggers
Withdrawal Signs
Substance Classifications
Evidenced Based Approaches
100

This core function determines whether a client is appropriate and eligible for admission or referral.

What is screening

100

When cravings are not managed, this may occur.

What is return to use.

100

These symptoms—such as muscle aches, nausea, diarrhea, yawning, and restlessness—may occur when a person stops or significantly reduces use of this substance. 

What are opioids

100

This drug class slows down the central nervous system and often includes alcohol and benzodiazepines.

What are Depressants?

100

This evidence‑based approach helps clients identify and change maladaptive thoughts and behaviors.

What is cognitive behavioral therapy (CBT)

200

This function involves completing required paperwork and obtaining signed consents to begin services.

What is intake

200

These often follow drug‑related thoughts and increase relapse risk.

What are cravings

200

These symptoms—such as tremors, sweating, anxiety, and nausea—may occur when a person suddenly stops or significantly reduces use. of this substance.

What is alcohol.

200

This drug class increases alertness, energy, and heart rate, often leading to decreased appetite.

What are Stimulants?

200

This approach is recommended at multiple points of intervention (pre‑pregnancy, prenatal, birth, postnatal) to improve outcomes for pregnant/parenting people who use opioids.

What is MOUD (Medication for Opioid Use Disorder)?

300

This function explains program rules, expectations, client rights, and hours of operation.

What is orientation

300

This tool is used to prepare responses to high‑risk situations.

What is a relapse prevention plan or recovery plan

300

This withdrawal syndrome includes prolonged mood, sleep, and concentration issues after acute withdrawal ends.

What is Post‑Acute Withdrawal Syndrome (PAWS)?

300

This class of drugs alters perception, mood, and thought processes, often causing hallucinations.

What are Psychedelics?

300

This approach aims to evoke “change talk” by shifting the provider stance from expert-driven persuasion to collaborative guiding.

What is Motivational Interviewing?

400

This function identifies a client’s strengths, weaknesses, and needs to support treatment planning.

What is assessment

400

This Dimension 1 trigger increases relapse risk when symptoms are untreated or unmanaged.

What is unmanaged withdrawal?

400

This serious withdrawal symptom includes confusion, agitation, and hallucinations, and are associated with alcohol intoxication.

What is delirium tremens?

400

This drug class includes substances derived from or acting on opioid receptors to relieve pain and produce euphoria.

What are Narcotics / Opioids?

400

The model’s core outcome target is “safety” defined behaviorally across substance use, relationships, emotions, and self-care—not trauma narrative work.

What is Seeking Safety

500

This function focuses on identifying needs the agency cannot meet and connecting clients to outside resources.

What is referral

500

This relapse prevention tool targets both internal and external triggers simultaneously. It also includes short term benefits vs. long term consequences. 

What is a functional analysis

500

These symptoms—such as irritability, impaired concentration, increased appetite, restlessness, depressed mood, and intense cravings—can emerge within hours to days after decreasing or discontinuing use of this substance.

What is nicotine. 

500

This class of drugs is primarily associated with feeling disconected, floaty, euphoria, or numb, and include substances like nitrous oxide and ketamine.

What are dissociatives?

500

This evidence‑based approach focuses on increasing psychological flexibility in response to triggers.

What is Acceptance and Commitment Therapy (ACT)?